NMPA Approval

Composite Potassium Hydrogen Phosphate Injection

Approval Number

国药准字H20254092

Company成都欣捷高新技术开发股份有限公司

Registration Date

May 13, 2025

Drug Information

Generic Name

复合磷酸氢钾注射液

Dosage Form

注射剂

Strength

5ml∶磷酸二氢钾1.12g和磷酸氢二钾（按K₂HPO₄计）1.18g

Drug Type

化学药品

Registration Date

May 13, 2025

Company Information

Applicant Company

Company Name成都欣捷高新技术开发股份有限公司

Company Address

成都高新区冯家湾工业园科园南路88号B7栋5楼

Manufacturing Company

Company Name山东华鲁制药有限公司

Company Address

山东省聊城市茌平区振兴街道华鲁街1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复合磷酸氢钾注射液 - NMPA 批准文号 | MedPath